Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma

ABSTRACT: MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma

PROVIDER: PRJNA488633 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [miRNA]

Project description:We have examined the both miRNA and mRNA expression profiles in 155 lung adenocarcinoma samples with known EGFR mutation status (52 mutated and 103 wild-type cases). An integrative analysis was performed to identify the unique miRNA-mRNA regulatory network in EGFR-mutated lung adenocarcinoma.

2018-11-13 | GSE119268 | GEO

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [mRNA]

2018-11-13 | GSE119267 | GEO

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [miRNA]

Project description:MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [miRNA]

| PRJNA488634 | ENA

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [mRNA]

Project description:MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [mRNA]

| PRJNA488635 | ENA

Unique microRNA profiles in EGFR-mutated lung adenocarcinomas

Project description:We have examined the microRNA expression in 154 lung adenocarcinoma samples and 20 paired normal lung tissue samples and investigated the microRNA expression to clinical variables, EGFR- and KRAS- mutational status and time to progression. 174 samples are analyzed. 154 from lung adenocarcinoma tumor tissue and 20 from paired normal lung tissue samples. No replicates or control samples included.

2014-03-10 | E-GEOD-48414 | biostudies-arrayexpress

MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-11-13 | GSE119269 | GEO

Unique microRNA profiles in EGFR-mutated lung adenocarcinomas

2014-03-10 | GSE48414 | GEO

Inhibition of EGFR signaling downregulates K-RAS mutated activity

Project description:KRAS mutations are the ost abundand driver mutations found in lung adenocarcinoma patients. Unfortunately, there are no clinical approved inhibitors available, to directly target mutant forms of KRAS. The aim of the study was to unravel the impact of upstream Egfr activation in signaling of mutated K-ras. We found that upregulation of G12D mutant Kras induced genes was significantly impaired when Egfr was knocked out. Our data suggests that signaling of mutant Kras depends on upstream activation. This finding may be exploited therapeutically by targeting EGFR in KRAS mutant patients.

2018-08-29 | GSE113146 | GEO

3' UTR RNA-sequencing of human EGFR-mutant lung adenocarcinoma cell lines treated with trametinib or controls

Project description:Human EGFR-mutated lung adenocarcinoma cell lines HCC4006, HCC827 and PC9 were treated with trametinib or DMSO to assess the impact on transcription.

2021-07-19 | E-MTAB-9889 | biostudies-arrayexpress

Expression Profiling of MicroRNAs in Relation to EGFR Mutation status in Japanese Smoker Male with Lung Adenocarcinoma [adinocarcinoma tissue]

Project description:The lung adenocarcinoma has an increased incidence in smokers. The molecular target therapy has been developed for lung adenocarcinoma patients harboring EGFR gene mutation. However, the treatment options for the patients without mutation are currently limited. Thus, analysis of EGFR gene mutation status at early stage is important strategy to classify patients for effective treatments and improving prognosis. This study aimed to identify microRNA (miRNAs) signature in relation to mutation status in EGFR gene in early stage of lung adenocarcinoma male patients with smoking history. MiRNA profiles were assessed by microarray in paired plasma and tissue pooled from 10 EGFR wild type (EGFR-wt) and 10 EGFR mutated (EGFR-mut) patients.

2018-02-14 | GSE102223 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data